NCT00143507View on ClinicalTrials.gov

The BEAUTIFUL Study: Effects of Ivabradine in Patients With Stable Coronary Artery Disease and Left Ventricular Systolic Dysfunction

PHASE3CompletedINTERVENTIONAL
Enrollment

10,917

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions
Coronary DiseaseVentricular Dysfunction, Left
Interventions
DRUG

Ivabradine

DRUG

Placebo

Trial Locations (1)

SW3 6NP

Royal Brompton National Heart and Lung Hospital, London

All Listed Sponsors
lead

Institut de Recherches Internationales Servier

OTHER

NCT00143507 - The BEAUTIFUL Study: Effects of Ivabradine in Patients With Stable Coronary Artery Disease and Left Ventricular Systolic Dysfunction | Biotech Hunter | Biotech Hunter